We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $25B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+18.87%
3 Year Est. Return
+73.23%
5 Year Est. Return
+90.52%
10 Year Est. Return
+458.69%
AUM
$3.19B
AUM Growth
+$153M
Cap. Flow
+$17.6M
Cap. Flow %
0.55%
Top 10 Hldgs %
29.55%
Holding
324
New
11
Increased
97
Reduced
113
Closed
9

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$27.5M
2
BSX icon
Boston Scientific
BSX
+$25.3M
3
LW icon
Lamb Weston
LW
+$6.07M
4
ADSK icon
Autodesk
ADSK
+$5.95M
5
FCFS icon
FirstCash
FCFS
+$5.8M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$34.4M
2
BKNG icon
Booking.com
BKNG
+$22.2M
3
WEC icon
WEC Energy
WEC
+$7.17M
4
MS icon
Morgan Stanley
MS
+$4.67M
5
INTC icon
Intel
INTC
+$4.26M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Financials 20.16%
3 Healthcare 11.15%
4 Consumer Staples 11.15%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBAY icon
201
eBay
EBAY
$49.3B
$697K 0.02%
17,650
-12,520
-41% -$471K
SKX
202
DELISTED
Skechers
SKX
$694K 0.02%
22,030
+1,775
+9% +$54.8K
VHT icon
203
Vanguard Health Care ETF
VHT
$17.8B
$670K 0.02%
3,854
FPA icon
204
First Trust Asia Pacific ex-Japan AlphaDEX Fund
FPA
$109M
$660K 0.02%
22,174
+1,270
+6% +$37.5K
MKL icon
205
Markel Group
MKL
$24.3B
$659K 0.02%
605
-40
-6% -$41.9K
SCHW
206
Charles Schwab
SCHW
$175B
$641K 0.02%
15,943
+495
+3% +$21.6K
FCX icon
207
Freeport-McMoran
FCX
$93.4B
$637K 0.02%
54,840
+1,700
+3% +$19.8K
BLK icon
208
Blackrock
BLK
$164B
$636K 0.02%
1,356
PGHY icon
209
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$222M
$635K 0.02%
27,407
-1,031
-4% -$23.9K
VTI icon
210
Vanguard Total Stock Market ETF
VTI
$661B
$623K 0.02%
4,151
-2,985
-42% -$440K
PFF icon
211
iShares Preferred and Income Securities ETF
PFF
$13.3B
$613K 0.02%
16,640
-335
-2% -$12.3K
DXCM icon
212
DexCom
DXCM
$27.6B
$599K 0.02%
16,000
IXC icon
213
iShares Global Energy ETF
IXC
$2.68B
$577K 0.02%
17,755
+730
+4% +$24K
CELG
214
DELISTED
Celgene Corp
CELG
$577K 0.02%
6,240
-394
-6% -$37.4K
ROBO icon
215
ROBO Global Robotics & Automation Index ETF
ROBO
$1.94B
$564K 0.02%
14,120
HSIC icon
216
Henry Schein
HSIC
$9.66B
$545K 0.02%
7,800
EXPE icon
217
Expedia Group
EXPE
$31.3B
$544K 0.02%
4,090
GDX icon
218
VanEck Gold Miners ETF
GDX
$23.4B
$544K 0.02%
21,280
+150
+0.7% +$3.31K
CHL
219
DELISTED
China Mobile Limited
CHL
$543K 0.02%
12,000
DEO icon
220
Diageo
DEO
$46.9B
$531K 0.02%
3,080
IWB icon
221
iShares Russell 1000 ETF
IWB
$48.3B
$528K 0.02%
3,241
+56
+2% +$8.97K
TJX icon
222
TJX Companies
TJX
$172B
$528K 0.02%
9,976
+56
+0.6% +$2.98K
FJP icon
223
First Trust Japan AlphaDEX Fund
FJP
$249M
$518K 0.02%
10,758
CEO
224
DELISTED
CNOOC Limited
CEO
$511K 0.02%
3,000
GD icon
225
General Dynamics
GD
$101B
$506K 0.02%
2,784
+362
+15% +$62.3K

Similar funds

Rathbones Group's Q2 2019 Portfolio in Review

As of Q2 2019, Rathbones Group held 324 positions worth $3.19B, up 5% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Rathbones Group's Q2 2019 filing shows 11 new, 97 increased, 113 reduced and 9 closed positions. Its largest new stake was RingCentral: 238,300 shares worth $27.4M. The largest sale was Abiomed Inc, an estimated $34.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Rathbones Group's largest Q2 2019 buy was RingCentral: 238,300 shares worth $27.4M.
  • Rathbones Group added most to Boston Scientific in Q2 2019, an estimated $25.3M increase.
  • Rathbones Group's biggest Q2 2019 reduction was Abiomed Inc, cutting an estimated $34.4M.
  • Rathbones Group fully exited Goldcorp Inc in Q2 2019, selling an estimated $461K.
  • Rathbones Group's ten largest holdings make up 30% of its $3.19B portfolio in Q2 2019.
  • Rathbones Group opened 11 new positions and closed 9 in Q2 2019.
  • Rathbones Group's portfolio value rose 5% quarter-over-quarter to $3.19B.

Based on Rathbones Group's 13F filing for Q2 2019, filed 12 Aug 2019.